GOFEN & GLOSSBERG LLC /IL/ - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOFEN & GLOSSBERG LLC /IL/ ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$17,000
-15.0%
10,0000.0%0.00%0.0%
Q2 2017$20,000
-50.0%
10,0000.0%0.00%
-50.0%
Q1 2017$40,000
-18.4%
10,0000.0%0.00%0.0%
Q4 2016$49,000
-36.4%
10,0000.0%0.00%
-33.3%
Q3 2016$77,000
+37.5%
10,0000.0%0.00%
+50.0%
Q2 2016$56,000
+3.7%
10,0000.0%0.00%0.0%
Q1 2016$54,000
-37.9%
10,0000.0%0.00%
-50.0%
Q4 2015$87,000
+3.6%
10,0000.0%0.00%0.0%
Q3 2015$84,00010,0000.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders